Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,720 | -8,241 | -4,654 | -2,926 | -1,087 |
| Depreciation Amortization | 239 | 950 | 701 | 463 | 216 |
| Accounts receivable | N/A | 1,169 | 1,169 | 218 | 191 |
| Other Working Capital | -631 | 119 | 153 | 1,130 | 1,020 |
| Other Operating Activity | 106 | -2,431 | -2,579 | -1,796 | -1,842 |
| Operating Cash Flow | $-3,006 | $-8,434 | $-5,210 | $-2,911 | $-1,502 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -84 | -93 | -37 | -23 | -11 |
| Other Investing Activity | 0 | -400 | -400 | -400 | 0 |
| Investing Cash Flow | $-84 | $-493 | $-437 | $-423 | $-11 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6 | -5,424 | -5,400 | -5,358 | -18 |
| Common Stock Issued | 9,197 | 5,105 | 1,081 | 366 | N/A |
| Financing Cash Flow | $9,191 | $-319 | $-4,319 | $-4,992 | $-18 |
| Beginning Cash Position | 8,346 | 17,592 | 17,592 | 17,592 | 17,592 |
| End Cash Position | 14,447 | 8,346 | 7,626 | 9,266 | 16,061 |
| Net Cash Flow | $6,101 | $-9,246 | $-9,966 | $-8,326 | $-1,531 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,006 | -8,434 | -5,210 | -2,911 | -1,502 |
| Capital Expenditure | -84 | -93 | -37 | -23 | -11 |
| Free Cash Flow | -3,090 | -8,527 | -5,247 | -2,934 | -1,513 |